Your browser is no longer supported. Please, upgrade your browser.
ENDP Endo International plc daily Stock Chart
Endo International plc
IndexS&P 500 P/E- EPS (ttm)-0.51 Insider Own0.20% Shs Outstand222.67M Perf Week4.78%
Market Cap4.63B Forward P/E4.21 EPS next Y4.95 Insider Trans0.00% Shs Float221.52M Perf Month2.71%
Income-58.80M PEG- EPS next Q0.81 Inst Own98.50% Short Float5.83% Perf Quarter17.50%
Sales3.70B P/S1.25 EPS this Y-482.50% Inst Trans-0.33% Short Ratio2.05 Perf Half Y-30.73%
Book/sh28.12 P/B0.74 EPS next Y8.63% ROA-5.00% Target Price26.58 Perf Year-59.56%
Cash/sh3.00 P/C6.94 EPS next 5Y4.43% ROE-15.60% 52W Range12.56 - 68.84 Perf YTD-66.01%
Dividend- P/FCF8.56 EPS past 5Y-21.90% ROI0.90% 52W High-69.77% Beta0.63
Dividend %- Quick Ratio0.70 Sales past 5Y13.80% Gross Margin30.50% 52W Low65.68% ATR1.02
Employees6406 Current Ratio0.90 Sales Q/Q25.30% Oper. Margin-31.70% RSI (14)51.03 Volatility3.70% 5.43%
OptionableYes Debt/Eq1.33 EPS Q/Q457.00% Profit Margin-25.90% Rel Volume0.60 Prev Close20.53
ShortableYes LT Debt/Eq1.31 EarningsNov 08 BMO Payout- Avg Volume6.30M Price20.81
Recom2.50 SMA200.24% SMA50-1.43% SMA200-25.50% Volume3,770,792 Change1.36%
Sep-29-16Upgrade Northland Capital Market Perform → Outperform
Aug-12-16Upgrade Mizuho Neutral → Buy $16 → $29
Jun-13-16Upgrade Mizuho Underperform → Neutral $13 → $16
Jun-06-16Initiated Goldman Neutral $20
May-18-16Reiterated Stifel Buy $75 → $25
May-09-16Reiterated Deutsche Bank Buy $61 → $31
May-06-16Reiterated Stifel Buy $90 → $75
May-06-16Reiterated Barclays Equal Weight $37 → $28
May-06-16Downgrade Piper Jaffray Overweight → Neutral
May-06-16Downgrade Mizuho Neutral → Underperform $42 → $13
May-06-16Downgrade Leerink Partners Outperform → Mkt Perform
Apr-21-16Initiated JMP Securities Mkt Outperform
Apr-18-16Reiterated Deutsche Bank Buy $65 → $61
Mar-28-16Reiterated Piper Jaffray Overweight $81 → $79
Mar-21-16Reiterated Deutsche Bank Buy $68 → $65
Mar-18-16Reiterated Deutsche Bank Buy $70 → $68
Mar-18-16Downgrade RBC Capital Mkts Top Pick → Outperform $73 → $47
Mar-04-16Reiterated Barclays Equal Weight $70 → $55
Mar-02-16Reiterated Mizuho Neutral $55 → $42
Mar-01-16Reiterated RBC Capital Mkts Top Pick $91 → $73
Oct-21-16 05:11PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
Oct-20-16 04:05PM  Endo Announces Departure of Chief Financial Officer PR Newswire
04:05PM  Endo Announces Departure of Chief Financial Officer CNW Group
Oct-18-16 07:00AM  Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016 PR Newswire
07:00AM  Endo to Announce Third Quarter 2016 Financial Results on November 8, 2016 CNW Group
Oct-17-16 03:04PM  Valeants Reorganization Efforts Could Boost Investor Confidence
01:17PM  Valeant Looks to Line Its Coffers Using These Five Strategies
Oct-15-16 01:09PM  Heres What Analysts Had to Say About These Trending Stocks at Insider Monkey
Oct-13-16 05:04PM  Valeant Thinks It Will Hit Its Financial Targets in 2016
01:53PM  Valuation Multiples: How Valeant Compares to Its Peers
Oct-12-16 01:28PM  These are the cheapest stocks in the marketbut beware a value trap: Technician at CNBC
Oct-11-16 07:16AM  Endo receives a vote of confidence
Oct-10-16 09:20AM  Repros' Secondary Hypogonadism Drug under Review in EU
Oct-06-16 03:02PM  Specialty Pharma: Drug Pricing Controversies Just Won't Die! at
Oct-05-16 10:04AM  Top 5 Pharma stocks with strong earnings momentum. : October 5, 2016 +5.05%
Oct-04-16 10:52AM  Endo International Plc Value Analysis (NASDAQ:ENDP) : October 4, 2016
Oct-03-16 05:23PM  Endo International Reports Positive Phase II Data on Xiaflex
08:37AM  Endo International Plc breached its 50 day moving average in a Bearish Manner : ENDP-US : October 3, 2016
Sep-30-16 02:04PM  What Are Analysts Saying about Mallinckrodt?
08:05AM  Better Buy: Valeant Pharmaceuticals International, Inc. vs. Endo International plc at Motley Fool
07:30AM  Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules PR Newswire
07:30AM  Endo Pharmaceuticals Presents New Phase 2 Data Evaluating the Safety and Effectiveness of XIAFLEX® (Collagenase Clostridium Histolyticum) for Dupuytren's Disease Nodules CNW Group
Sep-29-16 04:54PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi -6.40%
02:04PM  Why Teva and Regeneron Entered Collaboration Agreement
09:21AM  Endo Intl upgraded by Northland Capital
Sep-28-16 05:21PM  ENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
Sep-26-16 03:57PM  Endo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change -5.99%
03:01PM  Endo: The Good Feelings Didn't Last Long, Did They? at
11:12AM  Endo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps
09:17AM  Blog Coverage Change in Leadership at Endo Pharma
09:03AM  Changes at the Top for Endo Could Benefit Its Smaller Partners
06:59AM  7 Big-Volume Stocks to Trade for Big Gains
Sep-25-16 11:43AM  5 Trade Ideas for Monday: Endo, Fiesta Restaurant, JD, Worthington and Zions
Sep-23-16 05:35PM  Why Twitter, Endo International, and Hyster-Yale Materials Handling Jumped Today at Motley Fool +15.45%
04:51PM  The Hot Stock: Endo International Soars 15% on CEO Swap at
04:50PM  Yahoo and Facebook slip; Endo and AAR gain ground
04:46PM  [$$] Drugmaker Endo rises on leadership change at Financial Times
03:42PM  Why Endo International plc Jumped Higher Today at Motley Fool
02:23PM  Endo shares boosted by new CEO, upbeat guidance at CNBC
02:23PM  Pharma ETF Looks Healthy in a Sick Market After Endo Names New CEO
01:45PM  Why These 5 Stocks Are Winning Today at Insider Monkey
01:11PM  Endo Int'l: New CEO "Has His Work Cut Out For Him" at
11:25AM  Endo Shuffles the Deck With New CEO Appointment
10:40AM  Change at the top: Endo names new CEO at
10:13AM  Endo (ENDP) Stock Soars After Campanelli Named CEO
08:20AM  Endo Replaces CEO De Silva With Campanelli After Stock Slump at Bloomberg
07:14AM  Endo CEO De Silva steps down, replaced by former Par CEO at MarketWatch
07:00AM  Endo Names Paul Campanelli President and Chief Executive Officer PR Newswire
07:00AM  Endo Names Paul Campanelli President and Chief Executive Officer CNW Group
Sep-21-16 08:04AM  What Is the Upside Potential for Valeant?
Sep-20-16 11:04AM  How Will Valeants Profitability Pan Out over the Long Term?
10:04AM  Why Valeant Offers Volume-Based Discounts for These Drugs
Sep-19-16 12:59PM  Understanding Valeants Improved Valuation Multiple
Sep-11-16 05:09PM  Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression
Sep-09-16 05:26PM  Why Endo International plc Stock Gained 19.2% in August at Motley Fool
07:00AM  Drug Pricing Power Transcends Politics at Morningstar
Sep-07-16 10:00AM  AYTU: Reports 2016 Annual Results; Revenue Jumps 10-Fold In Just One Year!
07:00AM  Looking for Bargains? Check Out High-Quality Healthcare Stocks at Morningstar
Sep-06-16 10:26AM  Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids
Sep-05-16 09:35AM  Mylan's EpiPen Misclassified, Rebates Underpaid; Stock Down
Sep-03-16 08:00AM  Is EpiPen's Price The FDA's Fault? What's Holding Up New Generics?
Sep-02-16 03:45PM  Here's a Reason Why Endo (ENDP) Stock Is Lower Today
12:34PM  Two Stocks Most at Risk From Clinton's New Drug Plan at
Aug-31-16 11:23AM  ETFs with exposure to Endo International Plc : August 31, 2016
Aug-24-16 11:43AM  Five Small-Cap Stocks That Hedge Funds Were Dumping in Q2 at Insider Monkey -6.64%
Aug-19-16 12:51PM  ETFs with exposure to Endo International Plc : August 19, 2016
Aug-18-16 04:05PM  Endo's President and CEO Adopts 10b5-1 Trading Plan PR Newswire
04:05PM  Endo's President and CEO Adopts 10b5-1 Trading Plan CNW Group
11:53AM  Endo International Plc :ENDP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016
Aug-17-16 11:04AM  How Did Valeant Manage Its Operating Expenses in 2Q16?
Aug-16-16 04:48PM  Endo (ENDP) Withdraws Label Expansion Filing for Opana ER
Aug-15-16 05:25PM  Why AngloGold Ashanti, Mid-America Apartment Communities, and Endo International Slumped Today at Motley Fool
04:47PM Downgraded After Weak Sales-Channel Checks
02:42PM  Good, bad, ugly: XLY, SJM & ENDP
10:09AM  Is Valeant a Good Bet on a Price-to-Earnings Basis?
Aug-13-16 01:04PM  ENDO INTERNATIONAL PLC Financials
Aug-12-16 02:36PM  Endo withdraws filing seeking abuse deterrent labeling for pain drug at +5.08%
02:23PM  Endo (ENDP) Stock Climbs as Mizuho Upgrades to 'Buy'
11:06AM  Endo International: Baby Valeant Gets an Upgrade at
11:05AM  What Are Valeants New Segments?
09:50AM  Stocks Slip On July Data; Acacia Sparks Fly On Q2 Win
08:57AM  Morning Movers: JC Penney Jumps on Earnings; Macy's Slips on Downgrade at
08:34AM  Endo Pharma to withdraw application for new opioid painkiller formulation at MarketWatch
07:18AM  Endo Withdraws Its SNDA For OPANA, Shares Rise
07:17AM  Endo withdraws supplemental NDA for Opana, stock climbs 4.7% at MarketWatch
07:00AM  Endo Announces OPANA® ER Regulatory Update PR Newswire
07:00AM  Endo Announces OPANA® ER Regulatory Update CNW Group
Aug-11-16 05:41PM  Healthcare Growth Stocks in the S&P 500: Part 2
08:52AM  BioDelivery (BDSI) Q2 Loss Meets Estimates, Revenues Up
Aug-10-16 10:10AM  Stock Market News for August 10, 2016
Aug-09-16 05:37PM  Valeant, Endo and Monster Worldwide surge; Gap slackens +21.83%
05:23PM  Endo International shares surge after second-quarter earnings top estimates at CNBC
04:24PM  US STOCKS-Nasdaq hits record high, other indexes hover near highs Reuters
02:56PM  Street Talk: BWLD, JACK & more
02:36PM  Here's 5 Medical Stocks Soaring After Earnings Today
02:31PM  US STOCKS-Wall Street catches its breath after recent rally Reuters
02:28PM  Heres Why SINA Corp, Microchip Technology, Endo International & Other Stocks Are on the Move Today at Insider Monkey
01:48PM  Here's Why Endo (ENDP) Stock Is Spiking Today
11:30AM  US STOCKS-Health, tech stocks power S&P, Nasdaq to record highs
10:45AM  Valeant Isn't the Only Beaten-Down Specialty Pharma That's Flying Today at
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Branded Pharmaceuticals segment offers chronic pain management products, such as BELBUCA, OPANA ER, and Percocet; Lidoderm for opioid analgesics; and Voltaren gel for osteoarthritis pain, as well as XIAFLEX for treating Peyronie's and Dupuytren's contracture diseases. This segment also provides Supprelin LA for central precocious puberty treatment; testosterone replacement therapies, such as Aveed and TESTOPEL, as well as Fortesta and Testim gels; Frova and Sumavel DosePro for migraine headaches; Valstar, a sterile solution for intravesical instillation of valrubicin; and Vantas for the palliative treatment of prostate cancer. The company's U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; injectables for the treatment of pain, anti-infectives, cardiovascular, and other therapeutics areas; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company also provides Monarc subfascial hammock to treat female stress urinary incontinence; and Elevate transvaginal pelvic floor repair system for the treatment of pelvic organ prolapse. It sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.